Vitruvian Partners LLP Long-Term Concentrated

Location: London, United Kingdom

CIK: 0001692590 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 6, 2026

Total Value: $139M (100.0% shares, 0.0% debt)

Holdings (7)

HNGE HINGE HEALTH INC 41.7%

Value $58.06M Shares 1,250,000 Est. Cost $40.42 Unrealized +19.1%

MQ MARQETA 23.4%

Value $32.55M Shares 6,853,183 Est. Cost $29.82 Unrealized -83.9%

CARG CARGURUS INC 13.0%

Value $18.14M Shares 472,959 Est. Cost $29.39 Unrealized +22.6%

XMTR XOMETRY INC 8.2%

Value $11.41M Shares 191,919 Est. Cost $25.01 Unrealized +125.4%

GLBE GLOBAL-E 5.9%

Value $8.263M Shares 210,209 Est. Cost $44.64 Unrealized -16.9%

MXCT MAXCYTE 5.6%

Value $7.817M Shares 5,043,356 Est. Cost $12.03 Unrealized -86.7%

RXST RXSIGHT 2.1%

Value $2.906M Shares 278,865 Est. Cost $34.28 Unrealized -70.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
HNGE	HINGE HEALTH INC	1,250,000	$58.06M	41.7%	$40.42	+19.1%	CL A	433313103
MQ	MARQETA	6,853,183	$32.55M	23.4%	$29.82	-83.9%	CLASS A COM	57142B104
CARG	CARGURUS INC	472,959	$18.14M	13.0%	$29.39	+22.6%	COM CL A	141788109
XMTR	XOMETRY INC	191,919	$11.41M	8.2%	$25.01	+125.4%	CLASS A COM	98423F109
GLBE	GLOBAL-E	210,209	$8.263M	5.9%	$44.64	-16.9%	SHS	M5216V106
MXCT	MAXCYTE	5,043,356	$7.817M	5.6%	$12.03	-86.7%	COM	57777K106
RXST	RXSIGHT	278,865	$2.906M	2.1%	$34.28	-70.7%	COM	78349D107